Omeros Corp (OMER) is around the middle of the Biotechnology industry according to InvestorsObserver. OMER received an overall rating of 41, which means that it scores higher than 41 percent of all stocks. Omeros Corp also achieved a score of 33 in the Biotechnology industry, putting it above 33 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.
OMER has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on OMER!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Omeros Corp Stock Today?
Omeros Corp (OMER) stock is lower by -5.77% while the S&P 500 is up 1.13% as of 10:17 AM on Monday, Mar 18. OMER is lower by -$0.21 from the previous closing price of $3.65 on volume of 114,267 shares. Over the past year the S&P 500 is up 30.96% while OMER is up 5.85%. OMER earned $0.32 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 10.5.
Click Here to get the full Stock Report for Omeros Corp stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
